Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect.
about
Prostate cancer invasion and metastasis: insights from mining genomic data.Identification of FISH biomarkers to detect chromosome abnormalities associated with prostate adenocarcinoma in tumour and field effect environment.Methylation of APC and GSTP1 in non-neoplastic tissue adjacent to prostate tumour and mortality from prostate cancer.Diagnostic and prognostic utility of a DNA hypermethylated gene signature in prostate cancer.Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer.Characterization of a Gene Expression Signature in Normal Rat Prostate Tissue Induced by the Presence of a Tumor Elsewhere in the Organ.Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIMSynthesis and positron emission tomography evaluation of 18F-Glu-Urea-Lys, a prostate-specific membrane antigen-based imaging agent for prostate cancer.A basal stem cell signature identifies aggressive prostate cancer phenotypes.Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancerThe role of sarcosine metabolism in prostate cancer progression.Preparation and affinity identification of glutamic acid-urea small molecule analogs in prostate cancerClinically relevant genetic characterization of prostate tumors: how close are we to the goal?Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.Adenomatous polyposis coli mutants dominantly activate Hsf1-dependent cell stress pathways through inhibition of microtubule dynamics.Methylation in benign prostate and risk of disease progression in men subsequently diagnosed with prostate cancer.Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: evidence for a biologically meaningful field effect.Shared gene expression alterations in prostate cancer and histologically benign prostate from patients with prostate cancer.Using the epigenetic field defect to detect prostate cancer in biopsy negative patients.Characterisation of mobile lipid resonances in tissue biopsies from patients with cervical cancer and correlation with cytoplasmic lipid droplets.Integrative (epi) Genomic Analysis to Predict Response to Androgen-Deprivation Therapy in Prostate Cancer.Aberrant DNA methylation of the p16, APC, MGMT, TIMP3 and CDH1 gene promoters in tumours and the surgical margins of patients with oral cavity cancer.Advances in the computational and molecular understanding of the prostate cancer cell nucleusLongitudinal Raman Spectroscopic Observation of Skin Biochemical Changes due to Chemotherapeutic Treatment for Breast Cancer in Small Animal Model
P2860
Q30656758-47C9A72C-BF45-465E-A7C0-1B2C3718D369Q33592442-903A9E3B-EFC4-4DC5-B10B-9730182CFE10Q34847101-B357DC49-8316-4B8C-A7D7-072431347F20Q35120213-5A8426C9-FB16-4737-96DD-ED20080517E1Q35223291-E3DB7656-BD47-46CA-890D-89C78EADC095Q35664216-458EBCEF-BA43-4FC9-A82F-3248A609721BQ35839941-0CE6C6F2-75A9-482A-AD65-74993846EA06Q36085823-076A7BEE-3C45-4805-BADE-E395D017831BQ36332070-41307C60-6125-4D74-B225-C301F4559519Q36738856-11C11EC8-3E25-4E3B-AFB6-069999776410Q36801084-3F90A0CB-2658-438A-8733-37AE3EC78E33Q37108209-8A988DCF-3432-4179-A601-8702CDAC7C84Q38356863-8184C17F-AF1F-440A-8646-4BD21245E53EQ38602856-48B0C92F-22C6-48F2-BC7B-0CC0DC072C2DQ38839639-840330AA-B01E-45DC-9A36-55975551EC44Q40920100-82E4875D-2408-4C49-988B-23BD716E387AQ41609967-868AF2E3-A6BA-4E8F-B895-9CC4A56040D1Q42222737-15086B33-7526-497E-AB89-7661B16B3030Q42558314-797A7A54-6CF3-4B0B-9119-893B1B5DC442Q50494989-09D3179B-8A86-4026-9F9D-E375BB9FAD4DQ53692348-50E1807C-B1D2-481C-94E6-8A0F7EF005A8Q55306568-1DEF0A57-D681-4ACA-A2AB-FDF211DC83E3Q57107076-072BCBD2-2B7D-49EA-A9CB-EA623026BFD7Q59146977-106878A6-9DCA-47BA-BB18-B409264B2E3F
P2860
Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Differential gene expression i ...... prostate cancer field effect.
@ast
Differential gene expression i ...... prostate cancer field effect.
@en
type
label
Differential gene expression i ...... prostate cancer field effect.
@ast
Differential gene expression i ...... prostate cancer field effect.
@en
prefLabel
Differential gene expression i ...... prostate cancer field effect.
@ast
Differential gene expression i ...... prostate cancer field effect.
@en
P2093
P2860
P1476
Differential gene expression i ...... prostate cancer field effect.
@en
P2093
Beatrice S Knudsen
Daniel W Lin
Ilsa Coleman
Lawrence D True
Michael C Risk
Nolwenn LeMeur
Peter S Nelson
Robert C Gentleman
Ruth F Dumpit
P2860
P304
P356
10.1158/1078-0432.CCR-10-0272
P407
P577
2010-10-08T00:00:00Z